Background
Methods
Study group
Transthoracic echocardiography
Surgical procedures
N-terminal pro-B-type natriuretic peptide (NTproBNP) analysis
Statistical analysis
Results
Aortic regurgitation (n = 65) | Controls (n = 20) | p value | |
---|---|---|---|
Age (years) median (IQR) | 54 (46–63) | 59 (49–68) | 0.086 |
Male (n) | 56 (86%) | 11 (55%) | 0.009 |
Body surface area (m2) | 2.00 ± 0.19 | 1.96 ± 0.20 | 0.46 |
Body mass index (kg/m2) | 26.1 ± 4.0 | 26.3 ± 3.6 | 0.91 |
Systolic blood pressure (mmHg) | 145 ± 16 | 134 ± 15 | 0.011 |
Diastolic blood pressure (mmHg) | 70 ± 11 | 84 ± 9 | < 0.001 |
Diabetes (n) | 1 (1.5%) | 1 (5%) | 0.77 |
Hypertension (n) | 30 (46%) | 10 (50%) | 0.80 |
NYHA functional class | < 0.001 | ||
I | 16 (25%) | 18 (90%) | |
II | 39 (60%) | 2 (10%) | |
III | 10 (15%) | 0 | |
IV | 0 | 0 | |
NTproBNP (NPX units) | 4.4 ± 1.7 | 3.52 ± 1.3 | 0.043 |
Bicuspid aortic valve (n) | 38 (58%) | 9 (45%) | 0.29 |
LV size and function before and after surgery
Aortic regurgitation (n = 65) | Controls (n = 20) | Baseline comparison | |||||
---|---|---|---|---|---|---|---|
Baseline | Follow-up | p value | Baseline | Follow-up | p value | p value | |
Left ventricular indices | |||||||
End-diastolic diameter (mm) | 62.6 ± 6 | 49.3 ± 6 | < 0.001 | 48.5 ± 3 | 46.2 ± 4 | 0.005 | < 0.001 |
End-systolic diameter (mm) | 44.0 ± 7 | 34.4 ± 5 | < 0.001 | 33.1 ± 4 | 32.5 ± 4 | 0.80 | < 0.001 |
Interventricular septum (mm) | 11.7 ± 2.0 | 12.2 ± 1.7 | 0.004 | 11.3 ± 2.0 | 11.4 ± 1.7 | 0.71 | 0.48 |
Posterior wall thickness (mm) | 10.3 ± 1.4 | 9.5 ± 1.8 | 0.003 | 8.9 ± 1.7 | 9.3 ± 1.6 | 0.29 | < 0.001 |
End-diastolic volume (mL) | 224 ± 62 | 132.4 ± 36 | < 0.001 | 109 ± 20 | 111 ± 23 | 0.25 | < 0.001 |
End-diastolic volume index (mL/m2) | 113 ± 30 | 66 ± 17 | < 0.001 | 56 ± 9 | 57 ± 10 | 0.40 | < 0.001 |
End-systolic volume (mL) | 103 ± 41 | 57 ± 18 | < 0.001 | 43 ± 8 | 45 ± 11 | 0.25 | < 0.001 |
End-systolic volume index (mL/m2) | 52 ± 20 | 28 ± 8 | < 0.001 | 22 ± 4 | 23 ± 5 | 0.41 | < 0.001 |
Stroke volume (mL) | 121 ± 31 | 76 ± 22 | < 0.001 | 65 ± 14 | 66 ± 15 | 0.41 | < 0.001 |
Ejection fraction (%) | 55 ± 7.3 | 57 ± 7.1 | 0.027a | 60 ± 4 | 60 ± 7 | 0.79 | < 0.001 |
Global longitudinal strain (|%|) | 19.0 ± 3.0 | 19.4 ± 2.5 | 0.34 | 19.9 ± 2 | 19.6 ± 2 | 0.54 | 0.24 |
Left ventricular mass index (g/m2) | 81 ± 19 | 62 ± 16 | < 0.001 | 48 ± 11 | 48 ± 11 | 0.87 | < 0.001 |
Diastolic function indices | |||||||
Mitral E velocity (m/s) | 0.76 ± 0.2 | 0.73 ± 0.2 | 0.17 | 0.70 ± 0.2 | 0.76 ± 0.2 | 0.14 | 0.23 |
Mitral A velocity (m/s) | 0.58 ± 0.2 | 0.59 ± 0.2 | 0.84 | 0.63 ± 0.2 | 0.66 ± 0.2 | 0.38 | 0.30 |
Mitral E/A ratio | 1.5 ± 0.7 | 1.3 ± 0.5 | 0.063 | 1.3 ± 0.8 | 1.2 ± 0.6 | 0.93 | 0.17 |
Mitral E-wave Deceleration time (ms) | 205 ± 57 | 238 ± 52 | 0.001 | 212 ± 44 | 232 ± 52 | 0.11 | 0.66 |
Septal e′ (m/s) | 0.074 ± 0.02 | 0.075 ± 0.02 | 0.85 | 0.066 ± 0.02 | 0.070 ± 0.02 | 0.46 | 0.11 |
Lateral e′ (m/s) | 0.097 ± 0.03 | 0.12 ± 0.03 | 0.005 | 0.087 ± 0.02 | 0.10 ± 0.01 | 0.071 | 0.13 |
Mitral average E/e′ ratio | 9.3 ± 3 | 8.0 ± 3 | 0.012 | 10.2 ± 3 | 9.1 ± 2 | 0.31 | 0.30 |
Tricuspid regurgitation velocity (m/s) | 2.5 ± 0.3 | 2.3 ± 0.4 | 0.080 | 2.3 ± 0.2 | 2.3 ± 0.2 | 0.33 | 0.047a |
Diastolic dysfunction grade | |||||||
0 or 1 | 39 (60%) | 55 (85%) | 0.003 | 20 (100%) | 18 (90%) | 0.30 | 0.002 |
2 | 6 (9%) | 2 (3%) | 0 | 1 (5%) | |||
3 | 15 (23%) | 5 (8%) | 0 | 0 | |||
Indeterminate | 5 (8%) | 3 (4%) | 0 | 1 (5%) | |||
Left atrial indices | |||||||
Left atrial volume index (ml/m2) | 38.6 ± 12 | 32.2 ± 11 | < 0.001 | 26.8 ± 8 | 27.4 ± 8 | 0.70 | < 0.001 |
LASr (%) | 26.3 ± 6.7 | 29.0 ± 6.2 | 0.012 | 25.7 ± 6.0 | 25.8 ± 4.7 | 0.92 | 0.86 |
LAScd (%) | 15.6 ± 6.1 | 14.0 ± 4.5 | 0.037a | 12.1 ± 3.5 | 11.9 ± 3.7 | 0.28 | 0.081 |
LASct (%) | 11.0 ± 4.7 | 15.3 ± 5.5 | < 0.001 | 12.8 ± 5.6 | 13.8 ± 4.2 | 0.43 | 0.049a |
LV diastolic function and LA function before and after surgery
Aortic regurgitation (n = 60) | Controls (n = 20) | Overall p value | ||
---|---|---|---|---|
DD grades 0 or 1 (n = 39) | DD grades 2 or 3 (n = 21) | |||
LASr (%) | 27.9 ± 5.1* | 23.8 ± 7.8 | 25.7 ± 6.0 | 0.030 |
LAScd (%) | 15.3 ± 6.8 | 15.8 ± 6.8 | 12.1 ± 3.5 | 0.26 |
LASct (%) | 12.6 ± 4.2* | 8.0 ± 3.7† | 12.8 ± 5.6 | < 0.001 |
LASct/LASr ratio | 0.47 ± 0.15* | 0.34 ± 0.13† | 0.50 ± 0.14 | 0.001 |
NTproBNP (NPX units) | 3.79 ± 1.61* | 5.03 ± 1.54† | 3.53 ± 1.31 | 0.002 |
Determinants of impaired LV functional and structural recovery
Odds ratio (95% CI) | p value | RN2 | |
---|---|---|---|
Age | 0.96 (0.92–1.00) | 0.045 | 0.09 |
Gender | 0.6 (0.14–2.67) | 0.51 | 0.10 |
EDVi | 1.04 (1.02–1.07) | 0.001 | 0.29 |
ESVi | 1.07 (1.03–1.12) | 0.001 | 0.28 |
EF | 0.93 (0.86–1.01) | 0.091 | 0.07 |
GLS | 0.9 (0.75–1.08) | 0.26 | 0.03 |
Stroke work | 1.01 (1–1.02) | 0.040 | 0.10 |
DD grade ≤ 1 vs. ≥ 2 | 0.62 (0.2–1.89) | 0.40 | 0.02 |
E/e′ | 0.94 (0.82–1.08) | 0.40 | 0.02 |
LAVi | 0.99 (0.94–1.03) | 0.53 | 0.01 |
LASr | 1.1 (1–1.2) | 0.059 | 0.05 |
LAScd | 1.15 (1.03–1.28) | 0.010 | 0.17 |
LASct | 0,95 (0,84 – 1,07) | 0.36 | 0.02 |
NYHA I vs. II–III | 1.68 (0.52–5.43) | 0.38 | 0.02 |
NTproBNP | 0.98 (0.72–1.33) | 0.91 | 0.0 |
Model p | Accuracy (%) | Sensitivity (%) | Specificity (%) | RN2 | AUC (95% CI) | LRT p | |
---|---|---|---|---|---|---|---|
ESVi | < 0.001 | 69 | 59 | 77 | 0.28 | 0.78 (0.66–0.88) | |
Variable added to ESVi | |||||||
Age | < 0.001 | 69 | 59 | 77 | 0.33 | 0.78 (0.66–0.90) | 0.11 |
LAScd | < 0.001 | 70 | 65 | 74 | 0.42 | 0.83 (0.72–0.93) | 0.006 |
LASr | < 0.001 | 68 | 61 | 74 | 0.33 | 0.80 (0.69–0.91) | 0.10 |
Stroke work | 0.001 | 68 | 56 | 77 | 0.29 | 0.77 (0.65–0.89) | 0.70 |